InMode Receives Health Canada Certification of EmpowerRF Women's Wellness Technology

Rhea-AI Summary

InMode Ltd. (Nasdaq: INMD) has launched the EmpowerRF Women's Wellness technology in Canada after receiving certification from Health Canada. This advancement aims to improve urinary incontinence symptoms (SUI) and builds upon existing licenses for Genitourinary Syndrome of Menopause (GSM) and chronic pelvic pain. The EmpowerRF platform offers advanced therapies, including intravaginal electrical muscle stimulation and bipolar radiofrequency. InMode emphasizes its commitment to enhancing women's health through effective, minimally invasive solutions. This initiative reflects a strategic milestone for InMode in the global healthcare market.

Positive

• Health Canada certification allows the launch of EmpowerRF technology in Canada.
• The technology targets urinary incontinence and improves women's health issues.
• Innovative multi-functional platform showcases advanced medical technologies.

Negative

• None.

IRVINE, Calif., June 15, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is proud to announce the EmpowerRF Women's Wellness launch in Canada. InMode has recently received Health Canada certification to improve urinary incontinence symptoms (SUI). This adds to previous licences for improving the symptoms of Genitourinary Syndrome of Menopause (GSM), chronic pelvic pain, and blood circulation.

InMode's multi-functional platform is the most advanced and comprehensive feminine wellness solution available, leveraging synergistic complementary modalities, including intravaginal electrical muscle stimulation (EMS), fractional electrocoagulation of mucosa, and bipolar radiofrequency (RF). 

Shakil Lakhani, InMode North American President, commented, "The introduction of the EmpowerRF technology in Canada is a key milestone in our strategy to elevate the standard of care in feminine health globally. This further solidifies InMode's commitment to delivering powerful therapies that address the unmet needs of this important market."

"EmpowerRF is revolutionizing women's wellness everywhere. Its safe and highly efficacious minimally invasive life-changing treatments will significantly impact women's quality of life. Our ongoing multi-center studies assure us that women will no longer have to suffer in silence with these issues," said Dr. Spero Theodorou, InMode Chief Medical Officer and Plastic Surgeon.

About InMode 

InMode is a leading global provider of innovative medical technologies.  InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology.  For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

View original content:https://www.prnewswire.com/news-releases/inmode-receives-health-canada-certification-of-empowerrf-womens-wellness-technology-301568355.html

SOURCE InMode Ltd.

FAQ

What new technology has InMode launched in Canada?

InMode has launched the EmpowerRF Women's Wellness technology in Canada.

What conditions does EmpowerRF technology aim to treat?

EmpowerRF technology is designed to improve urinary incontinence symptoms and other women's health issues.

When did InMode receive certification from Health Canada?

InMode received certification from Health Canada on June 15, 2022.

What is the stock symbol for InMode?

The stock symbol for InMode is INMD.